US Bancorp’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.43K | Buy |
+271
| New | +$2.43K | ﹤0.01% | 3822 |
|
|
2025
Q1 | – | Sell |
-210
| Closed | -$1.58K | – | 4186 |
|
|
2024
Q4 | $1.58K | Buy |
+210
| New | +$1.58K | ﹤0.01% | 3891 |
|
|
2023
Q2 | – | Sell |
-1,126
| Closed | -$9.39K | – | 3962 |
|
|
2023
Q1 | $9.39K | Buy |
1,126
+1,042
| +1,240% | +$8.69K | ﹤0.01% | 3293 |
|
|
2022
Q4 | $964 | Sell |
84
-27
| -24% | -$310 | ﹤0.01% | 3907 |
|
|
2022
Q3 | $1K | Buy |
111
+27
| +32% | +$243 | ﹤0.01% | 3891 |
|
|
2022
Q2 | $1K | Sell |
84
-12,016
| -99% | -$143K | ﹤0.01% | 3902 |
|
|
2022
Q1 | $197K | Buy |
12,100
+500
| +4% | +$8.14K | ﹤0.01% | 1949 |
|
|
2021
Q4 | $161K | Buy |
11,600
+3,006
| +35% | +$41.7K | ﹤0.01% | 2061 |
|
|
2021
Q3 | $123K | Buy |
8,594
+194
| +2% | +$2.78K | ﹤0.01% | 2187 |
|
|
2021
Q2 | $133K | Sell |
8,400
-3,000
| -26% | -$47.5K | ﹤0.01% | 2147 |
|
|
2021
Q1 | $116K | Buy |
11,400
+9,400
| +470% | +$95.6K | ﹤0.01% | 2187 |
|
|
2020
Q4 | $15K | Buy |
+2,000
| New | +$15K | ﹤0.01% | 2998 |
|
|
2020
Q3 | – | Sell |
-1,000
| Closed | -$5K | – | 3635 |
|
|
2020
Q2 | $5K | Buy |
+1,000
| New | +$5K | ﹤0.01% | 3222 |
|
|
2019
Q4 | – | Sell |
-4,648
| Closed | -$13K | – | 3587 |
|
|
2019
Q3 | $13K | Hold |
4,648
| – | – | ﹤0.01% | 2977 |
|
|
2019
Q2 | $18K | Buy |
4,648
+4,302
| +1,243% | +$16.7K | ﹤0.01% | 2914 |
|
|
2019
Q1 | $3K | Buy |
+346
| New | +$3K | ﹤0.01% | 3332 |
|
|
2015
Q2 | – | Sell |
-384
| Closed | -$3K | – | 3562 |
|
|
2015
Q1 | $3K | Hold |
384
| – | – | ﹤0.01% | 3373 |
|
|
2014
Q4 | $5K | Hold |
384
| – | – | ﹤0.01% | 3262 |
|
|
2014
Q3 | $4K | Buy |
+384
| New | +$4K | ﹤0.01% | 3253 |
|